2020 Resolution on consolidating gains and accelerating efforts to control and eliminate malaria in developing countries, particularly in Africa, by 2030

74th UNGA

Analysis of precedential value

This res­o­lu­tion was adopted by the UN Gen­eral Assem­bly (UNGA) with­out a gen­eral vote in Sep­tem­ber 2020. The UNGA is the pre­em­i­nent gov­ern­ing body of the UN sys­tem and con­sists of all 193 UN Mem­ber States.

Used as precedent

key population and community leadership

Affirms that close col­lab­o­ra­tion with com­mu­nity lead­ers and imple­ment­ing part­ners, includ­ing non-gov­ern­men­tal orga­ni­za­tions, health work­ers and vol­un­teers, is an essen­tial fac­tor for suc­cess in com­bat­ing malaria, and calls upon Mem­ber States to intro­duce inte­grated, peo­ple-cen­tred com­mu­nity ser­vices, in coor­di­na­tion with health-care providers in the pub­lic and pri­vate sec­tors, and to con­tinue efforts to col­lab­o­rate with non-gov­ern­men­tal part­ners, health work­ers and vol­un­teers in imple­ment­ing com­mu­nity-based approaches to reach pop­u­la­tions in remote and hard- to-reach areas

access to health products

Calls upon Mem­ber States to pro­mote access to med­i­cines, and empha­sizes that access to afford­able and qual­ity med­i­cines and med­ical care in the event of sick­ness, as well as in the pre­ven­tion, treat­ment and con­trol of dis­eases, is cen­tral to the real­iza­tion of the right to the enjoy­ment of the high­est attain­able stan­dard of phys­i­cal and men­tal healthReaf­firms the right to use, to the fullest extent, the pro­vi­sions con­tained in the World Trade Orga­ni­za­tion Agree­ment on Trade-Related Aspects of Intel­lec­tual Prop­erty Rights (TRIPS Agree­ment), the Doha Dec­la­ra­tion on the TRIPS Agree­ment and Pub­lic Health, the deci­sion of the Gen­eral Coun­cil of the World Trade Orga­ni­za­tion of 30 August 2003 on the imple­men­ta­tion of para­graph 6 of the Doha Dec­la­ra­tion on the TRIPS Agree­ment and Pub­lic Health, and the lat­est amend­ment to arti­cle 31 of the TRIPS Agree­ment, which came into effect in Jan­u­ary 2017, which pro­vides flex­i­bil­i­ties for the pro­tec­tion of pub­lic health, and in par­tic­u­lar to pro­mote access to med­i­cines for all and to encour­age the pro­vi­sion of assis­tance to devel­op­ing coun­tries in this regard, and calls for the broad and timely accep­tance of the amend­ment to arti­cle 31 of the Agree­ment, as pro­posed by the Gen­eral Coun­cil of the World Trade Orga­ni­za­tion in its deci­sion of 6 Decem­ber 2005, while rec­og­niz­ing that the pro­tec­tion of intel­lec­tual prop­erty is impor­tant for the devel­op­ment of new med­i­cineCalls upon the inter­na­tional com­mu­nity to sup­port ways to expand access to afford­able, effec­tive and safe prod­ucts and treat­ments, such as vec­tor con­trol mea­sures, includ­ing indoor resid­ual spray­ing, long-last­ing insec­ti­ci­dal nets, includ­ing through the free dis­tri­bu­tion of such nets, ade­quate diag­nos­tic facil­i­ties, inter­mit­tent pre­ven­tive ther­a­pies for preg­nant women, chil­dren under 5 and infants, and artemisinin-based com­bi­na­tion ther­apy for pop­u­la­tions at risk of fal­ci­parum malaria infec­tion in endemic coun­tries, par­tic­u­larly in Africa, includ­ing through addi­tional funds and inno­v­a­tive mech­a­nisms, inter alia, for the financ­ing and scal­ing up of artemisinin pro­duc­tion and pro­cure­ment, as appro­pri­ate, to meet the increased need